Arvinas's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Arvinas last closed at $7.51 (+0.81%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 53.1×. Its overall grade ranks 46 of 738 stocks in Healthcare.
About this company
Arvinas last closed at $7.51 (+0.81%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 46/738
Valuation grade B-
Related stocks
- PfizerCustomer
ARV-471 등 공동개발/상업화 파트너로 가장 중요한 고객·협업사
- NovartisCustomer
Arvinas의 분자접착분해제(MGD) 플랫폼과 관련된 주요 제약 협력사로 거론됨
- Bristol Myers SquibbCustomer
표적 단백질 분해(TPD) 영역에서 협력 가능성이 큰 대형 제약사
About Arvinas
- What technical signals does Arvinas (ARVN) have?
- Arvinas current technical signals: no active technical signal.
- Is Arvinas a cup-and-handle pattern?
- No. Arvinas has no valid Cup signal right now.
- What published figures are available for Arvinas?
- Market cap: $482.32M. Trailing 12 months PER: 53.1×. Latest quarter PBR: 0.88×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Arvinas, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.